Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update
- Written by Newsfile
Berwyn, Pennsylvania--(Newsfile Corp. - May 4, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, today announced first quarter financial results for the quarter ended March 31, 2022, and provided a corporate update.
Maria L. Maccecchini, Ph.D., Founder,...